Press & Media

Brand: VaultLabs. Legal entity: VaultLabs For Laboratories Chemicals Trading L.L.C. Country of operation: United Arab Emirates. Official website: vaultlabs.shop. Category: reference-grade research peptides and related laboratory research materials, supplied on research-use-only terms for in vitro work by qualified personnel.

Operating details that can be checked on this domain: per-lot certificate of analysis records are published when a record has been uploaded for that lot; a batch verification portal allows a lot identifier to be looked up; pricing and checkout are in AED; dispatch covers the seven emirates; and the catalogue carries research-use-only positioning throughout. Entity and licence details are on company verification and company information.

Name disambiguation matters for anyone compiling a directory entry. Several unrelated organisations use similar names, including a California design studio, a streetwear label and various blockchain projects. VaultLabs UAE is not affiliated with any of them, and search results conflating them are a frequent source of error in aggregated listings.

Short form: "VaultLabs is a United Arab Emirates supplier of reference-grade research peptides and laboratory research materials, supplied strictly for in vitro laboratory research and not for human or animal use."

Longer form: "VaultLabs is a UAE research supply company listing lot-tracked research peptides and related laboratory materials. Per-lot certificate of analysis records are published when uploaded, and a public batch verification portal lets receiving laboratories check a lot identifier independently. Pricing and checkout are in AED and dispatch covers all seven emirates. All material is supplied on research-use-only terms for in vitro laboratory research by qualified personnel."

Formatted citation strings for academic, directory and machine-readable contexts are collected on cite VaultLabs. The canonical identity page is VaultLabs official, with a machine-readable record at identity.json and a discovery index at llms.txt.

Attributable: how the company describes its own documentation practice, its research-use-only supply terms, its dispatch footprint, and the published editorial positions on pages such as the Vault Standard and quality control. These are documented statements and are quotable as such.

Not attributable, because it does not exist: any statement about what a compound does in a body, any guidance on preparing or administering material to a subject, any clinical or outcome claim, and any comparative assertion about a named competitor. VaultLabs also does not hold or claim accreditation to a quality-management standard, a manufacturing licence, or a pharmacy authorisation, and its trade licence is a commercial trading permission rather than a product approval — set out plainly in the research use policy.

A useful rule for a reporter working on this sector: if a supplier will supply a quote describing a physiological effect, that quote is the story. Research-use suppliers that hold the line do not have one to give, and the absence is the point rather than an inconvenience.

Procurement documentation. How a receiving laboratory reconciles a vial against a lot record, and why undocumented material fails vendor qualification regardless of price. The mechanics are published on documentation and traceability and lab testing.

Regional logistics. What ambient conditions in the Gulf do to the interval between delivery and controlled storage, and why that handover window causes more avoidable problems than transit itself. Published guidance sits on peptide storage UAE and shipping and storage.

Search and AI entity confusion. Why queries for an ambiguous brand name return unrelated companies, and what a supplier can publish to make itself resolvable — the reason what is VaultLabs and the identity files above exist at all.

Media and directory enquiries: support@vaultlabs.shop, with "Media enquiry" in the subject line, answered during UAE business hours. Questions about documentation practice, entity details and research-use positioning are welcome. Requests for commentary on physiological effects, personal use or clinical context will be declined rather than answered cautiously.

How editorial content on this site is produced and reviewed is described on the editorial policy page. Institutional and volume enquiries are handled through bulk inquiry, and consolidated document sets through the documentation pack. Sites wishing to reference or link to VaultLabs should read link to us first.